This pronounced expression of RPS6KB2 in cholangiocarcinoma may be attributed to differences in transcriptional regulation, unique subcellular localization, or interactions with specific protein complexes, suggesting its distinct oncogenic functions in this cancer subtype. Here, RPS6KB2 is linked to cholangiocarcinoma.